...
首页> 外文期刊>Diagnostic pathology >Human telomerase RNA component (hTERC) gene amplification detected by FISH in precancerous lesions and carcinoma of the larynx
【24h】

Human telomerase RNA component (hTERC) gene amplification detected by FISH in precancerous lesions and carcinoma of the larynx

机译:FISH检测人癌前病变和喉癌中的人类端粒酶RNA成分(hTERC)基因扩增

获取原文
           

摘要

Background Gain of 3q26 is frequently observed in squamous cell carcinomas of mucosal origin, including those originating in the head and neck region. The human telomerase RNA component (hTERC) gene, which is located on chromosome 3q26, encodes for an RNA subunit of telomerase that maintains the length of telomeres through cellular divisions, and is activated in malignant diseases. The present study was designed to detect hTERC amplification in laryngeal lesions and evaluate whether this might serve as a supportive biomarker in histopathological analysis for in the diagnosis of laryngeal lesions. Methods Fluorescent in situ hybridization (FISH) was applied on formalin-fixed paraffin-embedded blocks of 93 laryngeal specimens, including 14 normal epithelium (NE), 15 mild dysplasia (Md), 18 moderate dysplasia (MD), 16 severe dysplasia (SD), 9 carcinoma in situ (CIS), and 21 invasive carcinoma (IC)). Results By histopathologic examination, hTERC amplification rates in NE, Md, MD, SD, CIS and IC cases were 0% (0/14), 13.33% (2/15), 72.22% (13/18), 81.25% (13/16), 100% (9/9) and 100% (21/21), respectively. Amplification of hTERC was significantly associated with histopathologic diagnosis (P < 0.0001). The percentage of hTERC amplification in patients with MD, SD, CIS, and IC was significantly higher than those with NE or Md (P < 0.0001). The number of cells with abnormal signals increased and the abnormal signal patterns were diversified with increasing severity of laryngeal dysplasia (P < 0.0001). Conclusions The hTERC amplification is important in the development of laryngeal squamous cell carcinoma (LSCC). FISH detection of hTERC amplification may provide an effective approach in conjunction with histopathologic evaluation for differential diagnosis of laryngeal lesions. Virtual Slides The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/2226606266791985 webcite
机译:在粘膜起源的鳞状细胞癌(包括那些起源于头颈部区域的鳞状细胞癌)中经常观察到3q26的背景增益。位于染色体3q26上的人类端粒酶RNA成分(hTERC)基因编码端粒酶的RNA亚基,该端粒酶通过细胞分裂维持端粒的长度,并在恶性疾病中被激活。本研究旨在检测hTERC在喉部病变中的扩增,并评估其是否可作为组织病理学分析中的支持性生物标志物,以诊断喉部病变。方法对93例喉标本经福尔马林固定石蜡包埋的块进行荧光原位杂交(FISH),包括14例正常上皮(NE),15例轻度不典型增生(Md),18例中度不典型增生(MD),16例严重不典型增生(SD) ),9例原位癌(CIS)和21例浸润性癌(IC))。结果通过组织病理学检查,NE,Md,MD,SD,CIS和IC患者的hTERC扩增率分别为0%(0/14),13.33%(2/15),72.22%(13/18),81.25%(13 / 16),100%(9/9)和100%(21/21)。 hTERC的扩增与组织病理学诊断显着相关(P <0.0001)。 MD,SD,CIS和IC患者的hTERC扩增百分比显着高于NE或Md患者(P <0.0001)。信号异常的细胞数量增加,并且信号异常的模式随着喉管异型增生的严重程度的增加而多样化(P <0.0001)。结论hTERC扩增在喉鳞状细胞癌的发展中起着重要的作用。 FISH检测hTERC扩增可能提供一种有效的方法,结合组织病理学评估对喉部病变进行鉴别诊断。虚拟幻灯片可以在这里找到本文的虚拟幻灯片:http://www.diagnosticpathology.diagnomx.eu/vs/2226606266791985 webcite

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号